PROPAFENONE HYDROCHLORIDE (propafenone) by Sinotherapeutics Inc is 1c antiarrhythmic drug with local anesthetic effects and a direct stabilizing action on myocardial membranes. First approved in 2019.
Drug data last refreshed 3h ago
1C antiarrhythmic drug with local anesthetic effects and a direct stabilizing action on myocardial membranes. The electrophysiological effect of propafenone manifests itself in a reduction of upstroke velocity (Phase 0) of the monophasic action potential. In Purkinje fibers, and, to a lesser…
Worked on PROPAFENONE HYDROCHLORIDE at Sinotherapeutics Inc? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Propafenone in the Treatment of Atrial Fibrillation